Drinkable molecule interferes with a crucial first step of Alzheimer’s
Yale University - 02-Jan-2019Improvements in laboratory technology enable mass screening of molecules like these
Join the club for FREE to access the whole archive and other member benefits.
Vincent Coates Professor of Neurology and director of Yale Alzheimer's Disease Research Center.
Stephen M. Strittmatter earned his undergraduate degree from Harvard College, summa cum laude, in 1980. He completed M.D. and Ph.D. training at Johns Hopkins in 1986 with mentorship from Solomon H. Snyder, M.D. He then moved to Massachusetts General Hospital for a medical internship and an Adult Neurology residency. While at Massachusetts General Hospital, he worked as a Research Fellow with Mark Fishman, M.D., exploring the molecular basis of axonal guidance. After a year as Fellow, he served briefly as an Assistant Professor at Harvard Medical School before moving to Yale University in 1993.
He currently holds the Vincent Coates Professorship of Neurology and co-founded the Yale Program in Cellular Neuroscience, Neurodegeneration and Repair. His research on axonal growth during development and regeneration has been recognized by honors from the Ameritec Foundation, the John Merck Fund, the Donaghue Foundation, the McKnight Foundation, the Jacob Javits Award of the NINDS and the American Academy of Neurology.
Visit website: https://medicine.yale.edu/adrc/profile/stephen_strittmatter/
See also: Yale University - Private Ivy League research university in New Haven, Connecticut
Details last updated 09-Jan-2020
Improvements in laboratory technology enable mass screening of molecules like these